Potential role of Fbxo22 in resistance to endocrine therapy in breast cancer with invasive lobular carcinoma
Saki Nakagawa(Okayama University), Takanori Ishida(Toho University), Atsushi Goda(St. Marianna University School of Medicine), Yasuyuki Kojima(St. Marianna University School of Medicine), Narumi Harada‐Shoji(Hammersmith Hospital), Yasuaki Sagara(National Sagamihara Hospital), Makoto Nakanishi(The Cancer Institute Hospital), Takashi Suzuki(Tohoku University), Ichiro Maeda(St. Marianna University School of Medicine), Tomohiko Ohta(St. Marianna University School of Medicine), Koichiro Tsugawa(St. Marianna University School of Medicine), Minoru Miyashita(Tohoku University), Hiroshi Tada(Tohoku University), Miku Sato(Tohoku University), Masakazu Amari(KKR Tohoku Kosai Hospital), Yasuyo Ohi, Akiko Ebata(Tohoku University)
Cited by 2
Related Papers
Navigating the DNA methylation landscape of cancer
|Trends in Genetics|2021|1k
Aberrant cell cycle checkpoint function and early embryonic death in <i>Chk1</i><sup>−/−</sup> mice
|Genes & Development|2000|469
Chk2‐deficient mice exhibit radioresistance and defective p53‐mediated transcription
|The EMBO Journal|2002|436